Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Clinical trial NCT06589089 · RECRUITING

Trial details

NCT number: NCT06589089
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2024-10-15
Primary completion: 2025-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.